Literature DB >> 21138605

The use of a wireless motility device (SmartPill®) for the measurement of gastrointestinal transit time after a dietary fibre intervention.

Derek Timm1, Holly Willis, William Thomas, Lisa Sanders, Thomas Boileau, Joanne Slavin.   

Abstract

Historically, measurement of gastrointestinal transit time has required collection and X-raying of faecal samples for up to 7 d after swallowing radio-opaque markers; a tedious, labour-intensive technique for both subjects and investigators. Recently, a wireless motility capsule (SmartPill®), which uses gut pH, pressure and temperature to measure transit time, has been developed. This device, however, has not been validated with dietary interventions. Therefore, we conducted a controlled cross-over trial to determine whether the device could detect a significant difference in transit time after ten healthy subjects (five men and five women) consumed 9 g of wheat bran (WB) or an equal volume, low-fibre control for 3 d. A paired t test was used to determine differences in transit times. Colonic transit time decreased by 10·8 (sd 6·6) h (P = 0·006) on the WB treatment. Whole-gut transit time also decreased by 8·9 (sd 5·4) h (P = 0·02) after the consumption of WB. Gastric emptying time and small-bowel transit time did not differ between treatments. Despite encouraging results, the present study had several limitations including short duration, lack of randomisation and unusable data due to delayed gastric emptying of the capsule. With minimal participant burden, the SmartPill technology appears to be a potentially useful tool for assessing transit time after a dietary intervention. This technology could be considered for digestive studies with novel fibres and other ingredients that are promoted for gut health.

Entities:  

Mesh:

Year:  2010        PMID: 21138605     DOI: 10.1017/S0007114510004988

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  14 in total

Review 1.  Methods for the assessment of small-bowel and colonic transit.

Authors:  Lawrence A Szarka; Michael Camilleri
Journal:  Semin Nucl Med       Date:  2012-03       Impact factor: 4.446

Review 2.  Dietary fibre in gastrointestinal health and disease.

Authors:  Samantha K Gill; Megan Rossi; Balazs Bajka; Kevin Whelan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-11-18       Impact factor: 46.802

3.  Biomedical IoT: Enabling Technologies, Architectural Elements, Challenges, and Future Directions.

Authors:  Mohammed Aledhari; Rehma Razzak; Basheer Qolomany; Ala Al-Fuqaha; Fahad Saeed
Journal:  IEEE Access       Date:  2022-03-14       Impact factor: 3.476

4.  Effects of Clozapine on the Gut: Cross-Sectional Study of Delayed Gastric Emptying and Small and Large Intestinal Dysmotility.

Authors:  Susanna Every-Palmer; Stephen J Inns; Eve Grant; Pete M Ellis
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

5.  Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability.

Authors:  Ivana R Sequeira; Roger G Lentle; Marlena C Kruger; Roger D Hurst
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

6.  Assessment of the Effect of Intestinal Permeability Probes (Lactulose And Mannitol) and Other Liquids on Digesta Residence Times in Various Segments of the Gut Determined by Wireless Motility Capsule: A Randomised Controlled Trial.

Authors:  Ivana R Sequeira; Roger G Lentle; Marlena C Kruger; Roger D Hurst
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

7.  A Pilot Randomized Cross-Over Trial to Examine the Effect of Kiwifruit on Satiety and Measures of Gastric Comfort in Healthy Adult Males.

Authors:  Alison Wallace; Sarah Eady; Lynley Drummond; Duncan Hedderley; Juliet Ansell; Richard Gearry
Journal:  Nutrients       Date:  2017-06-22       Impact factor: 5.717

8.  Issues in Continuous 24-h Core Body Temperature Monitoring in Humans Using an Ingestible Capsule Telemetric Sensor.

Authors:  Cathriona R Monnard; Elie-Jacques Fares; Julie Calonne; Jennifer L Miles-Chan; Jean-Pierre Montani; Dominique Durrer; Yves Schutz; Abdul G Dulloo
Journal:  Front Endocrinol (Lausanne)       Date:  2017-06-13       Impact factor: 5.555

9.  Effects of milk containing only A2 beta casein versus milk containing both A1 and A2 beta casein proteins on gastrointestinal physiology, symptoms of discomfort, and cognitive behavior of people with self-reported intolerance to traditional cows' milk.

Authors:  Sun Jianqin; Xu Leiming; Xia Lu; Gregory W Yelland; Jiayi Ni; Andrew J Clarke
Journal:  Nutr J       Date:  2016-04-02       Impact factor: 3.271

10.  Consumption of kiwifruit capsules increases Faecalibacterium prausnitzii abundance in functionally constipated individuals: a randomised controlled human trial.

Authors:  Paul Blatchford; Halina Stoklosinski; Sarah Eady; Alison Wallace; Christine Butts; Richard Gearry; Glenn Gibson; Juliet Ansell
Journal:  J Nutr Sci       Date:  2017-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.